DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL lifted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 45.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 96,129 shares of the medical instruments supplier's stock after acquiring an additional 30,200 shares during the period. Gamco Investors INC. ET AL's holdings in DENTSPLY SIRONA were worth $1,825,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in XRAY. Pacer Advisors Inc. boosted its stake in DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after purchasing an additional 4,473,972 shares during the last quarter. Nuance Investments LLC raised its position in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after buying an additional 2,708,097 shares during the last quarter. Norges Bank purchased a new position in shares of DENTSPLY SIRONA in the fourth quarter worth about $45,730,000. Cooke & Bieler LP boosted its position in DENTSPLY SIRONA by 24.3% during the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock worth $174,101,000 after acquiring an additional 1,794,391 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier acquired 15,142 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. 0.52% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Mizuho reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Evercore ISI restated an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Barrington Research reduced their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. Finally, Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Thirteen equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $22.58.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $12.83 on Friday. The firm has a 50-day simple moving average of $15.72 and a two-hundred day simple moving average of $18.82. The stock has a market cap of $2.56 billion, a PE ratio of -6.20, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $31.00. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.99%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.